This Week in Cannabis Investing News – Dec 13 to Dec 19 2021

5 Comments

1. I'm also skeptical of weedmaps. I expect their growth to disappoint over time.

   Reply

2. Hey Jordan. Thanks again for taking the time to make these helpful videos. Further to Opeoluwas request for an update on GDNS, I agree with you that they will likely be a benefactor of the industry's eventual acceptance and meteoric rise in stock prices. I don't see them as a takeover option, even with their NY license as a huge asset. From what little I know about them, I see them as a niche player as a medicinal cannabis sector operator. Management is great, fundamentals are strong and they are super focused. Given their current selling price ( $1.72 ) and knowing you're invested in this company at approx $2.82avg share price, ( I'm in at an average price of $2.56) would you consider buying more given the opportunity and the cash to average down or do you continue to focus on your workhorse Cresco labs.? I've been channeling my money to the big 5 MSO's exclusively for the past 6 months with all of them allowing me to average down right now. GDNS has huge upside. Your thoughts?

   Reply

3. Can you make an update on Vireo/Goodness growth since Newyork legalization.

   Reply

4. Nice video.

   Reply

5. 😎

   Reply